Abivax S.A.
ABVX · AAVXF · Pharmaceutical Preparations
Latest available SEC filing: SCHEDULE 13G/A ·
Latest disclosures
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Latest financial period: Q4 2025
Financial facts · Filed
-
Form 20-F
SEC filing · Filed
-
Form 20-F
SEC filing · Filed
-
Form 20-F
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- ABVX · 00370M103 - Ordinary Shares, par value Euro 0.01 per share
Company details and SEC sources
CIK 0001956827 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ABVX on Nasdaq, AAVXF on OTC
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 7 Bd Haussmann, Paris
- Incorporated in
- France
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields